Regeneron Pharmaceuticals Inc (WBO:REGN)
€ 757.4 -20.4 (-2.62%) Market Cap: 83.82 Bil Enterprise Value: 77.30 Bil PE Ratio: 20.51 PB Ratio: 3.11 GF Score: 99/100

Regeneron Pharmaceuticals Inc at Cowen HealthCare Conference Transcript

Mar 02, 2020 / 06:30PM GMT
Release Date Price: €406.75 (+2.92%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Okay. Welcome, everybody, once again to the 40th Annual Cowen Healthcare Conference here in Boston. I'm Yaron Werber, a biotech analyst here at Cowen. And it's a great pleasure to moderate now the fireside chat with Regeneron. We have with us Executive Vice President and CFO, Bob Landry, who's going to make some introductory remarks. And to my left, Justin Holko, Vice President of Investor Relations. So Bob, go for it, and then we'll go into the fireside chat. And afterwards, there's going to be a breakout session at the Tufts Room just on this floor.

Robert E. Landry
Regeneron Pharmaceuticals, Inc. - Executive VP of Finance & CFO

And Yaron, first off, thanks for having Regeneron here. Good afternoon, everybody here and for those that have joined us on the webcast.

So we have a bunch of slides we're going to try to blow through, Yaron, and then I'll come over and join Q&A. And as Yaron said, we are going to have a specific breakout session

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot